RepliCel Life Sciences (TSE:RP) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
RepliCel Life Sciences is urging shareholders to access its management information circular online due to possible postal delays caused by a Canada Post labor disruption. The company is preparing for a critical shareholders meeting to discuss the sale and licensing of its assets and potential delisting.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.